Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for olezarsen ...
The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...
Florida Atlantic University’sCollege of Business is launching a new MBA in Artificial Intelligence that will focus on preparing future business leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results